Study Evaluating ERB-041 in Active Crohn's Disease
NCT00245947
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
22
Enrollment
INDUSTRY
Sponsor class
Conditions
Crohn's Disease
Interventions
DRUG:
ERB-041
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer